Scalper1 News
Valeant Pharmaceuticals’ (VRX) bid to acquire Allergan (AGN) boosted the 42-stock Medical-Ethical Drugs industry group Tuesday. Valeant and hedge fund Pershing Square early Tuesday announced a plan to buy Allergan that values the Botox-maker at more than $47 billion. The announcement followed news of a deal late Monday. Valeant rose 7% in huge volume. Allergan soared more than 15% to a record high. Both stocks are among the group’s leaders, with Scalper1 News
Scalper1 News